Inflammation: Clinical Trials

515 trials for Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

515 completed. 515 Phase 2, 91 Phase 1, 73 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2515Completed 515
Phase 191Completed 91
Phase 373Completed 73

Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation

Trials (filtered) newest first · largest first

All 515 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease
Human Wharton's jelly mesenchymal stem cell (HWJ-MSC) exosomes, Human umbilical vein endothelial cell (HUVEC) exosomes, Placebo (0.9% sodium chloride) - Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4
Phase 1 / Phase 2CompletedNurhasan Agung Prabowo342026-07-012026-11-06
Chemical vs Mechanical Pleural Adhesiolysis for Liberation of Captive Pleura in Stacked Effusion
Intrapleural Hydrogen Peroxide (H_2O_2), Intrapleural Corticosteroids, Thoracoscopic Mechanical Pleurolysis - Pleural Infection, Pleural Adhesions
Phase 2CompletedDelta University for Science and Technology362026-03-262026-07-20
Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone
Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients, Neuroinflammation
Phase 2CompletedHasanuddin University802025-10-012026-05-12
Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases
GcMAF, Placebo Injection (Saline) - Inflammation
Phase 1 / Phase 2CompletedS.LAB (SOLOWAYS)1202025-09-012025-12-16
N-Acetylcysteine in Patients With Leptospirosis
N-acetylcysteine, Placebo - Leptospirosis
Phase 2CompletedDr Cipto Mangunkusumo General Hospital642025-08-302026-09-16
Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and Sepsis
Placebo Tablet(s), DLBS1033 - Pneumonia, Sepsis
Phase 2CompletedUniversitas Sebelas Maret502025-08-142026-10-23
A Study of NTRX-07 in Participants With Alzheimer's Disease
NTRX-07, Placebo - Alzheimer Disease, Mild Cognitive Impairment
Phase 2CompletedNeuroTherapia, Inc.482025-03-012026-10-29
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
EI-1071 tablet, oral - Mild, Moderate, or Severe Alzheimer's Disease
Phase 2CompletedElixiron Immunotherapeutics Inc.72024-12-162026-09-23
Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia
Structured Supportive Psychotherapy, Risperidone 2 mg - Schizophrenia, Cognitive Dysfunction
Phase 2CompletedHasanuddin University462024-12-012026-03-17
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases
Phase 2CompletedReveal Pharmaceuticals Inc.182024-08-152025-12-26
Effect of Bee Venom on T Regulatory Cells and Inflammation in Hemodialysis Patients: a Prospective Study Thesis
Bee Venom (BV) - Hemodialysis, Inflammation
Phase 1 / Phase 2CompletedMansoura University602024-06-012026-10-30
The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock
Norepinephrine, Ringer's Lactate - Septic Shock, Sepsis
Phase 2 / Phase 3CompletedUniversitas Indonesia422024-03-252024-06-20
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants
Cefiderocol, Standard of Care - Gram-Negative Bacterial Infections
Phase 2CompletedShionogi302024-03-142026-03-02
Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction
HT-6184, HT-6184 Placebo - Pain
Phase 2CompletedHalia Therapeutics, Inc.812024-02-122025-03-30
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
TIN816 70 mg lyophilisate powder, Placebo - Acute Kidney Injury Due to Sepsis
Phase 2CompletedNovartis Pharmaceuticals3162024-01-182026-07-29
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
VVN461 Ophthalmic Solution 1.0%, VVN461 Ophthalmic Solution 0.5%, Vehicle - Inflammation
Phase 2CompletedVivaVision Biotech, Inc912024-01-112026-09-11
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
Spermidine, Placebo - Ischemic Heart Disease, Myocardial Infarction
Phase 2CompletedUniversity of Aarhus1872024-01-012026-07-01
Multimodal Vasopressor Strategy in Septic Shock
Simultaneous administration of vasopressors, Successive administration of vasopressors - Shock, Septic
Phase 2 / Phase 3CompletedUniversity Medical Centre Maribor792023-12-232026-03-31
Single and Multiple Ascending Oral Doses of Avenanthramide
Avenanthramide, Placebo - Inflammation
Phase 1 / Phase 2CompletedMontreal Heart Institute922023-12-092026-04-20
A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage
Ir-CPI - Intracerebral Hemorrhage
Phase 2CompletedBioxodes S.A.232023-11-172026-07-23

Showing 20 of 515. Sign in to see all of them.

Narrower conditions

Sepsis (116)  ·  Shock, Septic (84)  ·  Cellulitis (19)  ·  Cytokine Release Syndrome (18)  ·  Pain (18)  ·  COVID-19 (16)  ·  Cardiovascular Diseases (14)  ·  Abscess (12)  ·  Atherosclerosis (12)  ·  Bacteremia (12)  ·  Metabolic Syndrome (12)  ·  Neuroinflammatory Diseases (12)  ·  Systemic Inflammatory Response Syndrome (12)  ·  Diabetes Mellitus, Type 2 (11)

Broader conditions

Pathological Conditions, Signs and Symptoms (515)  ·  Pathologic Processes (513)  ·  Infections (236)  ·  Systemic Inflammatory Response Syndrome (195)  ·  Shock (110)  ·  Respiratory Tract Diseases (68)  ·  Sepsis (67)  ·  Cardiovascular Diseases (65)  ·  Signs and Symptoms (61)  ·  Immune System Diseases (58)  ·  Lung Diseases (56)  ·  Vascular Diseases (55)  ·  Skin and Connective Tissue Diseases (51)  ·  Urogenital Diseases (51)

Interventions

Saline Solution (16)  ·  Sodium Chloride (16)  ·  Ascorbic Acid (13)  ·  Standard of Care (11)  ·  Interleukin 1 Receptor Antagonist Protein (9)  ·  salicylsalicylic acid (9)  ·  Thiamine (7)  ·  Daptomycin (6)  ·  Fish Oils (6)  ·  Glucose (6)  ·  Aspirin (5)  ·  Hydrocortisone (5)  ·  Ibuprofen (5)  ·  Metformin (5)  ·  Norepinephrine (5)

Sponsors

Beth Israel Deaconess Medical Center (7)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Virginia Commonwealth University (7)  ·  GlaxoSmithKline (6)  ·  Novartis Pharmaceuticals (6)  ·  Novo Nordisk A/S (6)  ·  University of Florida (6)  ·  University of Roma La Sapienza (6)  ·  Vanderbilt University (6)  ·  AstraZeneca (5)  ·  Radboud University Medical Center (5)  ·  Ain Shams University (4)  ·  Charite University, Berlin, Germany (4)  ·  Joslin Diabetes Center (4)  ·  National Eye Institute (NEI) (4)

Countries

United States (251)  ·  Canada (40)  ·  Germany (35)  ·  Spain (31)  ·  France (30)  ·  Italy (26)  ·  Netherlands (25)  ·  United Kingdom (25)  ·  Belgium (22)  ·  Denmark (20)  ·  Australia (16)  ·  Poland (16)  ·  Brazil (15)  ·  Egypt (15)  ·  Hungary (13)

Top investigators

Andrea Morelli, MD (5)  ·  Allison B. Goldfine, MD (4)  ·  Antonio Abbate, MD, PhD (3)  ·  Benjamin Van Tassell, PharmD (3)  ·  Eric Bellissant, MD, PhD (3)  ·  Issam Raad, MD (3)  ·  Michael W Donnino, MD (3)  ·  Wayne Dankner, MD (3)  ·  Yoghatama Cindya Zanzer, MSc (3)  ·  Andrea Morelli, M.D. (2)

Results publications

PMID 23001587, PMID 28159728, PMID 37916745, PMID 38321529, PMID 39230271, PMID 10379020, PMID 14987884, PMID 15713907, PMID 16003060, PMID 16505648, PMID 16507156, PMID 16636217, PMID 16980879, PMID 17076839, PMID 17206944, PMID 17429083, PMID 17551901, PMID 17558345, PMID 17617901, PMID 17636753, PMID 17660031, PMID 17715164, PMID 17720019, PMID 17825587, PMID 17896838, PMID 17950857, PMID 17959861, PMID 18413833, PMID 18668591, PMID 18674932, PMID 19017409, PMID 19048243, PMID 19114895, PMID 19114908, PMID 19172247, PMID 19196814, PMID 19220646, PMID 19454532, PMID 19590022, PMID 19664253, PMID 19733615, PMID 19797553, PMID 19944358, PMID 20231565, PMID 20441419, PMID 20520776, PMID 20597663, PMID 20613460, PMID 20634018, PMID 20689074

NIH funding

2017 (4), 2015 (3), 2019 (3), 2009 (2), R01HL095149 (2), U01DK074556 (2), U01HD019897 (2), U10HD021364 (2), U10HD021373 (2), U10HD021385 (2), U10HD021397 (2), U10HD021415 (2), 1KL2RR031989-01 (1), 1RF1AG051514 (1), 1UM1HL116885-01 (1)